Weave Communications, Inc.
$7.40+$0.01 (+0.1%)
Last close · Data as of Oct 23, 2026
- Market cap
- $459.1M
- P/E
- -16.4x
- EV / EBITDA
- -42.3x
- Revenue
- $239.0M
- Net margin
- -11.7%
- ROCE
- -24.8%
Price chart
Technical chartScreen technicals →Hidden because the last close is more than three trading days older than the latest prices of its class.
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 23 Oct 2026 close.
- 1M
- Stale
- 3M
- Stale
- 6M
- Stale
- 1Y
- Stale
- 5Y
- Stale
- Hidden because the last close is more than three trading days older than the latest prices of its class.
52-week range
Day change +$0.01 (+0.1%) from $7.39 to $7.40 · Last close Oct 23, 2026
Best weekday to invest, historically
The same weekly amount in WEAV, bought on each weekday since 2021.
News & filings
What Weave Communications filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockConcernThe company made a net loss of 28.1 million US dollars in fiscal 2025.
Strengths (1)
- Revenue grew 17.0% in fiscal 2025.
- Prices are as of 23 Oct 2026; price-based points are paused until newer prices arrive.
Prices to the 23 Oct 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
Weave Communications, Inc. operates an AI-powered patient communications, engagement, and payments platform for small and medium-sized healthcare businesses.
Read moreShow less
Weave Communications, Inc. operates an AI-powered patient communications, engagement, and payments platform for small and medium-sized healthcare businesses. It offers AI-receptionist; Unified Phone Number; Customized Phone System, a smarter phone system to identify whether incoming calls are from new or current patients, provide information at every call, and manage heavy call times; Softphones to make and receive calls from anywhere with an internet connection; Text Messaging and SMS response assistant; Missed Call Text that allows practices to respond when a call is missed; Missed Text Auto-Reply that replies to patient text messages by automatically responding to messages received outside of a practice's normal operating hours; Team Chat, a group messaging solution; and Weave Mobile App. It also provides Weave Reviews and Respond Assistant to request, collect, monitor, and respond to reviews; Weave Email Marketing and Email Assistant to create professional emails; Text Connect to interact with their patients online directly through their websites; and Weave Payments, a payment processing solution. The company provides Weave Digital Forms to collect patient information; Online Scheduling that allows patients to request appointments from the practice's website, send automatic scheduling reminders, and personalize each reminder for the patient; Insurance Eligibility, an insurance tool; Insurance Verification; Practice Analytics that provides real-time data on patient retention, appointment scheduling, treatment acceptance rates, and revenue generation; Call Intelligence; and Weave Enterprise for multi-location healthcare practices comprising dental service organizations, vision, veterinary, and medical groups. The company was formerly known as Recall Solutions, LLC and changed its name to Weave Communications, Inc. in October 2015. Weave Communications, Inc. was founded in 2008 and is headquartered in Lehi, Utah.
- Sector
- Healthcare
- Shares outstanding
- 78.3M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $459.1M
- P/E
- -16.4x
- P/B
- 5.6x
- EV / EBITDA
- -42.3x
- EV / Sales
- 1.9x
- P/S
- 1.9x
- 52-week high
- $7.59
- 52-week low
- $4.37
Profitability
- Operating margin
- -12.8%
- Net margin
- -11.7%
- EBITDA margin
- -4.5%
- ROE
- -34.1%
- ROCE
- -24.8%
- ROIC
- -27.1%
- ROA
- -13.5%
- Asset turnover
- 1.15
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $239.0M
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 17.0%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- 18.9%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -1.0%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- $12.9M
Solvency
- Current ratio
- 1.24
- Debt / Equity
- 0.63
- Debt / Assets
- 0.25
- CFO / Net profit
- -0.63
- Cash / Market cap
- 12.0%
Where the revenue went
FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.
| Line | FY2025 |
|---|---|
| Revenue | $239.0M |
| Cost of revenue | $66.7M |
| Gross profit | $172.3M |
| Operating expenses | $202.9M |
| Research and development | $44.5M |
| Selling, general and administrative | $158.5M |
| Operating income | -$30.6M |
| Interest and other | $1.6M |
| Pretax income | -$29.0M |
| Tax and other | -$930.0k |
| Net income | -$28.1M |
Revenue and net profit
Revenue grew 17.0% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $142.1M | -$49.7M |
| FY2023 | $170.5M | -$31.0M |
| FY2024 | $204.3M | -$28.3M |
| FY2025 | $239.0M | -$28.1M |
Cash flows
FY2025: $17.5M from operations, $12.9M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | -$12.8M | -$15.9M |
| FY2023 | $10.2M | $6.5M |
| FY2024 | $14.1M | $10.4M |
| FY2025 | $17.5M | $12.9M |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $239.0M+17.0%1Y
- EBITDA
- -$10.8M
- Net profit
- -$28.1M
- Cash from operations
- $17.5M+24.0%1Y
- Free cash flow
- $12.9M+24.1%1Y
- Revenue CAGR, 3Y
- 18.9%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $239.0M | -$10.8M | -$28.1M | $12.9M | -34.1% | +17.0% | -1.0% |
Monthly returns
Month-by-month returns of WEAV across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $208.0M |
| Current assets | $105.0M |
| Non-current assets | $103.0M |
| Liabilities | $125.6M |
| Current liabilities | $84.6M |
| Non-current liabilities | $41.0M |
| Equity | $82.4M |
| Paid-in capital | $401.6M |
| Retained earnings | -$319.1M |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Healthcare companies placed by value, growth and quality; WEAV highlighted.
P/E against peers
Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Weave Communications, Inc.WEAVthis company | $459.1M | -16.4x | 5.6x | -34.1% | -42.3x |
| The Oncology Institute, Inc.TOI | $473.9M | -7.8x | -30.1x | 385.5% | -12.8x |
| CTEVCTEV | $470.0M | — | — | 163.5% | 10.8x |
| OrthoPediatrics Corp.KIDS | $464.9M | -11.7x | 1.3x | -11.4% | -69.2x |
| Editas Medicine, Inc.EDIT | $458.9M | -2.9x | 16.8x | -586.6% | -2.2x |
| NRC HealthNRC | $445.1M | 38.4x | 31.8x | 82.9% | 17.2x |
| Myriad Genetics, Inc.MYGN | $443.0M | -1.2x | 1.2x | -99.4% | -1.5x |
| Varex Imaging CorporationVREX | $440.9M | — | 0.9x | -14.9% | 973.8x |
| Emergent BioSolutions Inc.EBS | $435.5M | 8.3x | 0.8x | 10.1% | 3.4x |
| Peer median | — | -2.0x | 1.2x | -0.7% | 0.9x |
Year-to-date ROI
WEAV since 1 January, against earlier years.
Historical volatility
WEAV's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2022 | -35.0% |
| FY2023 | -20.2% |
| FY2024 | -15.4% |
| FY2025 | -12.8% |
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $239.0M |
| Cost of revenueCost Of Revenue | $66.7M |
| Gross profitGross Profit | $172.3M |
| Operating expensesOperating Expense | $202.9M |
| Research and developmentResearch And Development | $44.5M |
| Selling, general and administrativeSelling General And Administration | $158.5M |
| Total expensesTotal Expenses | $269.6M |
| Operating incomeOperating Income | -$30.6M |
| Interest and other | |
| Pretax incomePretax Income | -$29.0M |
| TaxTax Provision | -$920.0k |
| Net incomeNet Income | -$28.1M |
| Per share | |
| Supplementary |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $208.0M |
| Current assetsCurrent Assets | $105.0M |
| Non-current assetsTotal Non Current Assets | $103.0M |
| LiabilitiesTotal Liabilities Net Minority Interest | $125.6M |
| Current liabilitiesCurrent Liabilities | $84.6M |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $41.0M |
| EquityTotal Equity Gross Minority Interest | $82.4M |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $17.5M |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $17.5M |
| Net income, continuing operationsNet Income From Continuing Operations | -$28.1M |
| Depreciation and amortisationDepreciation And Amortization | $16.5M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $16.5M |
| Depreciation | $15.6M |
| Amortization cash flowAmortization Cash Flow | $870.0k |
| Amortization of intangiblesAmortization Of Intangibles | $870.0k |
| Amortization of securitiesAmortization Of Securities | -$900.0k |
| Stock-based compensationStock Based Compensation | $32.1M |
| Operating gains and lossesOperating Gains Losses | $10.0k |
| Provision and write off of assetsProvisionand Write Offof Assets | $1.1M |
| Change in working capitalChange In Working Capital | -$18.1M |
| Other non-cash itemsOther Non Cash Items | $14.8M |
| Investing cash flowInvesting Cash Flow | -$6.8M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$6.8M |
| Capital expenditureCapital Expenditure | -$4.7M |
| Capital expenditure (reported)Capital Expenditure Reported | -$2.3M |
| Purchase of PP&EPurchase Of PPE | -$2.4M |
| Net PP&E purchases and salesNet PPE Purchase And Sale | -$2.4M |
| AcquisitionsPurchase Of Business | -$23.9M |
| Net acquisitions and disposalsNet Business Purchase And Sale | -$23.9M |
| Purchase of investmentsPurchase Of Investment | -$36.8M |
| Sale of investmentsSale Of Investment | $58.5M |
| Net investment purchases and salesNet Investment Purchase And Sale | $21.7M |
| Other investing changesNet Other Investing Changes | — |
| Financing cash flowFinancing Cash Flow | -$7.3M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$7.3M |
| Debt issuedIssuance Of Debt | — |
| Debt repaidRepayment Of Debt | -$7.2M |
| Net debt issuedNet Issuance Payments Of Debt | -$7.2M |
| Short-term debt issuedShort Term Debt Issuance | — |
| Short-term debt repaidShort Term Debt Payments | — |
| Net short-term debt issuedNet Short Term Debt Issuance | — |
| Long-term debt repaidLong Term Debt Payments | -$7.2M |
| Net long-term debt issuedNet Long Term Debt Issuance | -$7.2M |
| Shares issuedIssuance Of Capital Stock | — |
| Common stock issuedCommon Stock Issuance | — |
| Net common stock issuedNet Common Stock Issuance | — |
| Common stock repurchasedCommon Stock Payments | — |
| Share buybacksRepurchase Of Capital Stock | — |
| Stock options exercisedProceeds From Stock Option Exercised | $2.7M |
| Preferred stock issuancePreferred Stock Issuance | — |
| Net preferred stock issuanceNet Preferred Stock Issuance | — |
| Other financing chargesNet Other Financing Charges | -$2.9M |
| Change in cashChanges In Cash | $3.4M |
| Cash at the start of the yearBeginning Cash Position | $51.6M |
| Cash at the end of the yearEnd Cash Position | $55.0M |
| Free cash flowFree Cash Flow | $12.9M |
| Supplemental |
Learn while you research
Academy chapters picked for Weave Communications, Inc. and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
- 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read